Antioxidant Response in Human X-Linked Adrenoleukodystrophy Fibroblasts.

Area of Science:

• Biochemistry
• Neuroscience
• Genetics

Background:

• X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disease linked to ABCD1 gene mutations.
• Accumulation of very long chain fatty acids (VLCFAs) and redox imbalance are key pathological features.
• The exact role of VLCFAs in X-ALD phenotypes and their connection to oxidative stress are not fully understood.

Purpose of the Study:

• To investigate the role of ferroptosis in X-ALD pathogenesis.
• To analyze ferroptosis pathway expression in X-ALD patient fibroblasts.
• To evaluate N-acetylcysteine (NAC) treatment efficacy for X-ALD.

Main Methods:

• Analysis of GPX4-glutathione and NQO1-CoQ10 ferroptosis pathways in fibroblasts from X-ALD patients (AMN and cALD forms).
• Assessment of lipid peroxide accumulation and ferroptosis-counteracting enzyme expression.
• Evaluation of N-acetylcysteine (NAC) treatment efficacy.

Main Results:

• Lipid peroxides accumulate in X-ALD fibroblasts.
• Ferroptosis-counteracting enzymes are dysregulated in X-ALD fibroblasts.
• Distinct antioxidant responses were observed between the AMN and cALD forms of X-ALD.

Conclusions:

• Ferroptosis is a significant contributor to X-ALD development and progression.
• Dysregulated ferroptosis pathways and lipid peroxide accumulation are characteristic of X-ALD.
• Findings suggest potential for novel therapeutic strategies targeting ferroptosis and oxidative stress in X-ALD.